According to Tempest Therapeutics's latest financial reports the company's current earnings (TTM) are -A$45.39 M. In 2023 the company made an earning of -A$42.06 M an increase over its 2022 earnings that were of -A$51.14 M.The earnings displayed on this page is the company's Pretax Income.